SYT » Topics » Martin Taylor: additional information

This excerpt taken from the SYT 6-K filed Sep 2, 2005.

Martin Taylor: additional information

Martin Taylor's career has spanned the worlds of finance, industry, public policy and journalism.

After studying Chinese at Oxford University he worked for Reuters in Paris, Frankfurt and London, before moving to the Financial Times where he wrote for the Lex column.

In 1982, at the age of 30, he went to work for Courtaulds plc, becoming responsible for the textile division in 1987. This business was spun off as Courtaulds Textiles plc in 1990 with Martin as its Chief Executive. At the end of 1993 he became CEO of Barclays plc and served there for five years.

 

Syngenta – 2 September 2005 / Page 1 of 2






Since 1999 he has been an adviser to Goldman Sachs International, where he chairs the asset management company and the audit and compliance committee. He has held non-executive posts at the British retailer WHSmith plc (Chairman, 1999-2003), the Luxembourg-based media company RTL Group sa, where he is currently Vice Chairman, and the US biotech company Antigenics Inc. He chairs the pension trust at WHSmith.

He has advised the British Government on a number of financial policy issues, and was for five years a member of its Council for Science and Technology. He was also Chairman of the Commission set up by the UK Institute of Public Policy Research on public/private partnerships.

Martin Taylor has two daughters in their twenties and a four-year-old son. He travels enthusiastically and is interested in art, language, music, literature and architecture.

He speaks French, German and Italian in addition to English, his mother tongue.

 

Syngenta is a world-leading agribusiness committed to sustainable agriculture through innovative research and technology. The company is a leader in crop protection, and ranks third in the high-value commercial seeds market. Sales in 2004 were approximately $7.3 billion. Syngenta employs some 20,000 people in over 90 countries. Syngenta is listed on the Swiss stock exchange (SYNN) and in New York (SYT). Further information is available at www.syngenta.com.

Media Enquiries:  Switzerland:    Rainer von Mielecki  Tel:  +41 (61) 323 2323 
  USA:    Sarah Hull  Tel:  +1 (202) 628 2372
           
Analysts/Investors:  Switzerland:    Jonathan Seabrook  Tel:  +41 (61) 323 7502
      Jennifer Gough  Tel:  +41 (61) 323 5059
  USA:    Rhonda Chiger  Tel:  +1 (917) 322 2569

 

Cautionary Statement Regarding Forward-Looking Statements

This document contains forward-looking statements, which can be identified by terminology such as ‘expect’, ‘would’, ‘will’, ‘potential’, ‘plans’, ‘prospects’, ‘estimated’, ‘aiming’, ‘on track’ and similar expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements. We refer you to Syngenta's publicly available filings with the U.S. Securities and Exchange Commission for information about these and other risks and uncertainties. Syngenta assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors. This document does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer, to purchase or subscribe for any ordinary shares in Syngenta AG, or Syngenta ADSs, nor shall it form the basis of, or be relied on in connection with, any contract therefore.

Syngenta – 2 September 2005 / page 2 of 2





SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

SYNGENTA AG
       
Date: September 2, 2005 By: /s/ Christoph Mäder

Name: Christoph Mäder
Title: General Counsel
         
    By: /s/ Damian Heller

Name: Damian Heller
Title: Company Secretary
       
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki